Pharmacokinetics of nevirapine: initial single-rising-dose study in humans.
Nevirapine, a nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, was administered for the first time to humans in a pilot study designed to investigate the pharmacokinetics and tolerance of the drug following single-dose administration to 21 HIV-1-infected...
Збережено в:
| Опубліковано в:: | Antimicrob Agents Chemother |
|---|---|
| Автори: | , , , , , , , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Microbiology (ASM)
1993
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187634/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8452345/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.2.178 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|